Repligen Corporation (RGEN) Stock

Repligen Corporation (RGEN) is a Healthcare stock trading at $131.99 (as of 2026-06-18), with a market capitalization of $6.99B and a trailing P/E of 136.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Repligen develops and commercializes bioprocessing technologies and systems for biological drug manufacturing. Its offerings include Protein A ligand and chromatography products (e.g., affinity resins and OPUS columns), along with filtration systems, dialysis products, and related assay kits, which are used by biopharmaceutical manufacturers.

Valuation — source: SEC EDGAR (first-party)
Price$131.99
Market Cap$6.99B
P/E Ratio136.2
EV / EBITDA48.2
Price / Book3.32
Price / Sales9.16
DCF Value (model)$42.48
DCF Upside vs Price-67.8%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$738.26M
Net Margin6.6%
Return on Equity2.4%
Debt / Equity0.26
Current Ratio9.20
Revenue Growth (YoY)14.8%
EPS Growth (YoY)50.0%
FCF Growth (YoY)106.1%
Financial Health — source: SEC EDGAR
Altman Z-Score6.22 (safe)
Piotroski F-Score7/9 (strong)
Valuation vs Sector & Industry
Stock P/E136.2
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector549.9%
vs Industry689.1%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($818.31M)
Institutional Holders Tracked10
Congressional Trades (recent)6
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOOlivier Loeillot
Employees1,778
CountryUS
IPO Date1986-04-29

Related Companies (Business model: Clinical Labs / CRO Services + Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Align Technology, Inc. (ALGN)
  • Revvity, Inc. (RVTY)
  • Charles River Laboratories International, Inc. (CRL)
  • Baxter International Inc. (BAX)
  • Bio-Rad Laboratories, Inc. (BIO)
  • Onto Innovation Inc. (ONTO)
  • Avantor, Inc. (AVTR)
  • Caris Life Sciences, Inc. (CAI)
RGEN earnings history · RGEN institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.